CELU250117P7500
- 5.30
- 0.000.00%
Celularity Newsroom
10-Q: Q3 2024 Earnings Report
Celularity Gets Back On Track With Quarterly Submissions; Q3 Revenue Jump 145%
Celularity Reports Q3 EPS (73c) Vs. ($4.98) Last Year
Express News | Celularity Inc: Filed Quarterly Report on Form 10-Q for Period Ended Sept 30, & Now Current With Quarterly Report Filings
Express News | Celularity Reports Over Sevenfold Growth in Net Product Sales Through Third Quarter 2024 Compared to Third Quarter 2023
Press Release: Celularity Reports Over Sevenfold Growth in Net Product Sales Through Third Quarter 2024 Compared to Third Quarter 2023
Celularity's Strategic Partner Announces Groundbreaking For Stem Cell & Regenerative Medicine Center In Asia Pacific
Express News | Celularity Shares Are Trading Higher. The Nasdaq Listing Qualifications Hearings Panel Has Cancelled the Previously Scheduled Hearing Regarding the Company's Non-compliance
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
Sector Update: Health Care Stocks Rise Late Afternoon
Celularity CELU Increased Sales Guidance; Ensysce ENSC NASDAQ Extension
Top Midday Gainers
Express News | Celularity Shares Halted To The Upside; Stock Now Up 161.38%
10-Q: Q2 2024 Earnings Report
12 Health Care Stocks Moving In Thursday's Intraday Session
Celularity Raises FY24 Revenue View to $54M-$60M From $50M-$56M
Express News | Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
Press Release: Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
Celularity to Submit 510(k) Notification for Tendon Wrap in Early 2025
Express News | Celularity : Intend to File Form 10-Q for Q2 2024 Within Coming Weeks